News & Updates

First-line, reduced-dose eribulin mesylate disappoints in older adults with metastatic breast cancer
First-line, reduced-dose eribulin mesylate disappoints in older adults with metastatic breast cancer
27 Sep 2022

Among older patients with metastatic breast cancer, first-line treatment with reduced-dose eribulin mesylate is reasonably safe but yields a low disease control rate, reports a recent phase II trial.

First-line, reduced-dose eribulin mesylate disappoints in older adults with metastatic breast cancer
27 Sep 2022
Radical prostatectomy tied to higher survival than radiotherapy in prostate cancer
Radical prostatectomy tied to higher survival than radiotherapy in prostate cancer
27 Sep 2022
Mammography uptake among Malay-Muslim women low, blamed on multilevel factors
Mammography uptake among Malay-Muslim women low, blamed on multilevel factors
26 Sep 2022 byJairia Dela Cruz

Breast cancer screening behaviour among Malay-Muslim women in Singapore appears to hinge on multilevel factors that involve not only personal relationships but also their religious beliefs and screening facilities’ availability and access.

Mammography uptake among Malay-Muslim women low, blamed on multilevel factors
26 Sep 2022
HIIT, resistance training boost wellbeing in chronic lymphocytic leukaemia
HIIT, resistance training boost wellbeing in chronic lymphocytic leukaemia
22 Sep 2022

Patients with chronic lymphocytic leukaemia (CLL) may benefit from an exercise regimen consisting of high-intensity interval training (HIIT) and resistance training (RT), which could lead to better functional and general wellbeing, as well as a lower burden of lymphoma-specific symptoms, reports a recent study.

HIIT, resistance training boost wellbeing in chronic lymphocytic leukaemia
22 Sep 2022